GENE ONLINE|News &
Opinion
Blog

IPO
Soon-To-Be J&J Spinoff, Kenvue Files for $100 Million IPO
2023-01-06
Alkermes to Break Oncology Sector into Independent Company
2022-11-03
Shenzhen Joincare Plots $300 Million IPO On Swiss Exchange
2022-06-20
Forbion Looks to Fund IPO Ambitious Companies With Its €470 Million Fund
2022-06-10
Belite Bio Clears Biopharma IPO Drought, with HilleVax and Tenon Medical Close Behind
2022-05-03
Top 10 Biotech IPOs on NASDAQ in 2021
2022-01-19
Vertex Is Looking to Become Singapore’s First SPAC
2022-01-10
RNAi Player Sirnaomics Squeezes in $50 Million IPO in Hong Kong
2022-01-03
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Shanghai Startup Poised for $325M IPO on Nasdaq
2021-10-21
Oxford Nanopore Soars on London Market Debut
2021-10-05
Cue Health’s $200 Million Nasdaq IPO: Where Will the Ball Roll Next?
2021-09-27
Oxford Nanopore Gears Up for Highly-Anticipated LSE IPO
2021-09-03
Singapore Exchange to Allow SPAC Listings on the Mainboard
2021-09-03
Revelation Goes the SPAC Way to list on Nasdaq
2021-08-31
1 2 3 4
LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!